Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT study.
Saved in:
| Title: | Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT study. |
|---|---|
| Authors: | Beer TM; Knight Cancer Institute, Oregon Health and Science University, Portland, OR 98239, United States., George DJ; Duke Cancer Institute, Duke University Shool of Medicine, Durham, NC, United States., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, United States., Winters-Stone K; Knight Cancer Institute, Oregon Health and Science University, Portland, OR 98239, United States.; Division of Oncological Sciences, School of Medicine, Oregon Health and Science University, Portland, OR, United States., Wefel JS; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Verholen F; Bayer Consumer Care, Basel, Switzerland., Srinivasan S; Bayer Healthcare Pharmaceuticals, Inc., Whippany, NJ, United States., Ortiz J; Bayer Healthcare Pharmaceuticals, Inc., Whippany, NJ, United States., Morgans AK; Dana-Farber Cancer Institute, Boston, MA, United States. |
| Source: | The oncologist [Oncologist] 2025 Jul 04; Vol. 30 (7). |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39450762 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Beer+TM%22">Beer TM</searchLink>; Knight Cancer Institute, Oregon Health and Science University, Portland, OR 98239, United States.<br /><searchLink fieldCode="AU" term="%22George+DJ%22">George DJ</searchLink>; Duke Cancer Institute, Duke University Shool of Medicine, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Shore+ND%22">Shore ND</searchLink>; Carolina Urologic Research Center, Myrtle Beach, SC, United States.<br /><searchLink fieldCode="AU" term="%22Winters-Stone+K%22">Winters-Stone K</searchLink>; Knight Cancer Institute, Oregon Health and Science University, Portland, OR 98239, United States.; Division of Oncological Sciences, School of Medicine, Oregon Health and Science University, Portland, OR, United States.<br /><searchLink fieldCode="AU" term="%22Wefel+JS%22">Wefel JS</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Verholen+F%22">Verholen F</searchLink>; Bayer Consumer Care, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Srinivasan+S%22">Srinivasan S</searchLink>; Bayer Healthcare Pharmaceuticals, Inc., Whippany, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Ortiz+J%22">Ortiz J</searchLink>; Bayer Healthcare Pharmaceuticals, Inc., Whippany, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Morgans+AK%22">Morgans AK</searchLink>; Dana-Farber Cancer Institute, Boston, MA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2025 Jul 04; Vol. 30 (7). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Clinical Trial, Phase II; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39450762 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/oncolo/oyae287 Languages: – Code: eng Text: English Titles: – TitleFull: Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Beer TM – PersonEntity: Name: NameFull: George DJ – PersonEntity: Name: NameFull: Shore ND – PersonEntity: Name: NameFull: Winters-Stone K – PersonEntity: Name: NameFull: Wefel JS – PersonEntity: Name: NameFull: Verholen F – PersonEntity: Name: NameFull: Srinivasan S – PersonEntity: Name: NameFull: Ortiz J – PersonEntity: Name: NameFull: Morgans AK IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 07 Text: 2025 Jul 04 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1549-490X Numbering: – Type: volume Value: 30 – Type: issue Value: 7 Titles: – TitleFull: The oncologist Type: main |
| ResultId | 1 |